Delhi High Court has refused to provide Sun Pharmaceuticals any interim relief in their trademark infringement case against rival drug manufacturer Mylan Laboratories for production of cancer medication Oxaliplatin.
Tags : DELHI HIGH COURT MYLAN LABORATORIES OXALIPLATIN
Share :